How many studies have been conducted on Beta 2 Glycoprotein I?

BiohacksAI has indexed 299 PubMed studies on Beta 2 Glycoprotein I, including 1 randomized controlled trials (RCTs). 48% of studies involve human subjects.

What are the main research areas for Beta 2 Glycoprotein I?

The primary research domains for Beta 2 Glycoprotein I are 🔥 Metabolic, ❤️ Cardiovascular, 🛡️ Immunity. This is based on analysis of 299 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Beta 2 Glycoprotein I

A 44-kDa highly glycosylated plasma protein that binds phospholipids including CARDIOLIPIN; APOLIPOPROTEIN E RECEPTOR; membrane phospholipids, and other anionic phospholipid-containing moieties. It plays a role in coagulation and apoptotic processes. Formerly known as apolipoprotein H, it is an autoantigen in patients with ANTIPHOSPHOLIPID ANTIBODIES.

299+ PubMed studies analyzed · 1 RCTs · Evidence Score: 53.6

Research Domains

Beta 2 Glycoprotein I has been studied across 11 research domains including 🔥 Metabolic, ❤️ Cardiovascular, 🛡️ Immunity, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 🔥 Metabolic with 63% of studies addressing this area.

Loading evidence profile...

This evidence profile for Beta 2 Glycoprotein I is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.